![[ Visit the Fifth Decennial online ]](images/banner.gif)
Sunday, March 21, 2010: 4:00 PM-6:00 PM
Centennial I-II (Hyatt Regency Atlanta)
CME Credits: 2
Type: Oral
Summary: In the absence of the development of new antimicrobial agents to treat infections caused by emerging MDROs, antimicrobial stewardship is a vital weapon in the war against resistance. The IDSA/SHEA Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship was published in January 2007. While antimicrobial stewardship will soon be required in the EU, adoption and dissemination of the guidelines has been slow in the US. This session will explain the new EU regulations and explore the limitations of the science of antimicrobial stewardship, and then focus on moving the field forward during the next decade.
Learning Objectives: - Discuss the development, implementation, and compliance with EU regulations mandating antimicrobial stewardship programs.
- Understand the difficulty of demonstrating the impact of antimicrobial stewardship and the limitations of current study designs.
- Discuss the gaps in current knowledge concerning the impact of antimicrobial stewardship and define what is needed to move the science forward in this area.
Co-Organized by:
Society of Infectious Diseases Pharmacists (SIDP)
Moderators:
Herman Goossens, PhD
and
J. Todd Weber, MD